Prednisone (and methylprednisolone)

DRUG3 trials

Conditions

ANCA Associated Systemic Vasculitis Including Wegener'sAntineutrophil Cytoplasmic Antibody (ANCA)-associated Nephritis (AAGN)Granulomatosis and Microscopic Polyangiitis andImmune Checkpoint Inhibitor-Related ColitisRenal Limited Vasculitis

Phase 1

The Efficacy and Safety of Treatment with Telitacicept in Antineutrophil Cytoplasmic Antibody-associated Nephritis (AAGN)

Active, not recruitingNCT06656962

Renmin Hospital of Wuhan UniversityAntineutrophil Cytoplasmic Antibody (ANCA)-associated Nephritis (AAGN)

Start: 2024-10-10End: 2026-10-30Updated: 2024-10-24

Phase 2

Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial

RecruitingNCT06841705

Shilpa Grover, MD, MPHImmune Checkpoint Inhibitor-Related Colitis

Start: 2025-07-15End: 2026-12-31Target: 80Updated: 2025-11-04

Phase 3

IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic Vasculitis

TerminatedNCT00307645

Assistance Publique - Hôpitaux de ParisANCA Associated Systemic Vasculitis Including Wegener's, Granulomatosis and Microscopic Polyangiitis and, Renal Limited Vasculitis

Start: 2003-05-31End: 2009-08-31Target: 160Updated: 2006-04-10

Related Papers

Negative anti-neutrophil cytoplasm antibody at switch to maintenance therapy is associated with a reduced risk of relapse.

2017-06-0738 citations

Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial.